Target Corporation — Fiscal 2022 Form 10-K
Reporting period: Fiscal year ended January 28, 2023 (52 weeks), compared with the year ended January 29, 2022. This filing reports annual results, not standalone 2021 Q4 results. Target operates as a single U.S.-focused retail segment; its fourth quarter is typically seasonally important because it includes the holiday period.
Financial performance
| Metric | Fiscal 2022 | Fiscal 2021 |
|---|---|---|
| Total revenue | $109.1 billion | $106.0 billion |
| Sales | $107.6 billion; up 2.8% | $104.6 billion |
| Comparable sales | Up 2.2% | Up 12.7% |
| Operating income | $3.8 billion; down 57.0% | $8.9 billion |
| Operating margin | 3.5% | 8.4% |
| Net earnings | $2.8 billion | $6.9 billion |
| Diluted EPS | $5.98 GAAP; $6.02 adjusted | $14.10 GAAP; $13.56 adjusted |
| Operating cash flow | $4.0 billion | $8.6 billion |
| Gross margin rate | 23.6% | 28.3% |
Cost of sales rose 9.7%, faster than sales, while SG&A increased 4.6%. Management attributed the margin decline principally to heavier promotional and clearance markdowns, inventory impairments, higher merchandise and freight costs, supply-chain costs, and increased inventory shrink. Lower incentive compensation partly offset higher expenses, including wage investments.
Liquidity, debt and capital allocation
- Cash and cash equivalents were $2.2 billion at year-end, down from $5.9 billion. Inventory was $13.5 billion, compared with $13.9 billion.
- Long-term debt and other borrowings were $16.0 billion, plus $130 million current; the comparable amounts were $13.5 billion and $171 million. Target had no commercial paper outstanding at year-end.
- Target reported unused committed revolving credit facilities totaling $4.0 billion and stated that operating cash flow, credit capacity, and capital-market access should cover foreseeable requirements. Its long-term ratings were A2 (Moody’s), A (S&P), and A (Fitch).
- Capital expenditures were $5.5 billion. Management expects approximately $4.0–$5.0 billion in fiscal 2023, including investments in remodels, new stores, and supply-chain capacity.
- Dividends paid were $1.8 billion; share repurchases totaled $2.6 billion. The company declared $4.14 per share in dividends during fiscal 2022.
Material changes and management commentary
Comparable-sales growth slowed substantially from the prior year. Growth in Beauty & Household Essentials and Food & Beverage was substantially offset by declines in discretionary categories, including Apparel, Hardlines, and Home. Comparable traffic increased 2.1%, while average transaction amount rose 0.1%. More than half of digital sales used same-day fulfillment options; stores fulfilled 96.7% of total sales.
Target increased promotions and markdowns, removed excess inventory, and cancelled purchase orders as demand shifted. Improved supply-chain timing also brought some inventory earlier than expected, increasing the cost of managing elevated inventory and working-capital needs. Operating cash flow fell due to lower earnings and lower accounts-payable leverage, partly offset by reduced inventory investment. Fiscal 2023 will have 53 weeks.
There is no full-year sales or earnings guidance in the provided filing text; the stated fiscal 2023 outlook includes capital expenditures of $4.0–$5.0 billion, about 70 remodels, and approximately 20 new stores. Target also reported a $335 million pretax gain on the sale of Dermstore in fiscal 2021, which affects year-over-year comparability. Fiscal 2022 adjusted EPS excludes $20 million pretax of other items; adjusted EPS is a non-GAAP measure.
Risks, contingencies and unusual items
- Elevated inventory shrink, changing consumer demand, markdown exposure, inflation, and supply-chain disruption could pressure sales and margins.
- Other material risks include competition and execution of digital and store investments; cybersecurity and data privacy; labor availability and costs; vendor and sourcing issues; macroeconomic conditions; and climate and severe-weather impacts.
- Target disclosed ongoing legal and tax uncertainties but said identified litigation was not expected to materially affect results, cash flows, or financial condition. It cautioned that unfavorable rulings could have a material effect.
- Real-estate obligations for signed but not commenced leases and facility commitments were $5.3 billion, about half due within one year. Purchase obligations were $1.0 billion.
- The independent auditor issued unqualified opinions on the financial statements and internal control over financial reporting.
Investor verification priorities
- Review whether gross-margin recovery is achievable and how shrink, markdowns, freight, and inventory costs evolve.
- Track discretionary-category demand, comparable sales, traffic, and average transaction value against the prior-year comparisons.
- Assess whether operating cash flow can support planned capital spending, dividends, and repurchases while debt remains elevated.
- Examine the timing and returns of the $4.0–$5.0 billion fiscal 2023 capital plan and related lease commitments.
- Confirm reported adjusted EPS reconciliations and distinguish the fiscal 2021 Dermstore gain from recurring performance.